SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Carl R. Walkley, Bone Cancer, 2015,

    CrossRef

  2. 2
    Q. Tian, J. Jia, S. Ling, Y. Liu, S. Yang, Z. Shao, A causal role for circulating miR-34b in osteosarcoma, European Journal of Surgical Oncology (EJSO), 2014, 40, 1, 67

    CrossRef

  3. 3
    Richard B. Richardson, Age-specific bone tumour incidence rates are governed by stem cell exhaustion influencing the supply and demand of progenitor cells, Mechanisms of Ageing and Development, 2014, 139, 31

    CrossRef

  4. 4
    Maria V. Guijarro, Steven C. Ghivizzani, C. Parker Gibbs, Animal Models in Osteosarcoma, Frontiers in Oncology, 2014, 4,

    CrossRef

  5. 5
    K. E. Holmes, V. Thompson, C. M. Piskun, R. A. Kohnken, M. K. Huelsmeyer, T. M. Fan, T. J. Stein, Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro, Veterinary and Comparative Oncology, 2014, 12, 4
  6. 6
    Anthony J. Mutsaers, Carl R. Walkley, Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?, Bone, 2014, 62, 56

    CrossRef

  7. 7
    Wanli Ma, Xuhua Zhang, Jie Chai, Peng Chen, Peng Ren, Mingzhi Gong, Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma, Tumor Biology, 2014,

    CrossRef

  8. 8
    V. R. Lo Vasco, M. Leopizzi, C. Puggioni, C. Della Rocca, Ezrin silencing remodulates the expression of Phosphoinositide-specific Phospholipase C enzymes in human osteosarcoma cell lines, Journal of Cell Communication and Signaling, 2014, 8, 3, 219

    CrossRef

  9. 9
    Qingbing Meng, Jie Zhao, Hongbing Liu, Guoyou Zhou, Wensheng Zhang, Xingli Xu, Minqian Zheng, HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma, Tumor Biology, 2014,

    CrossRef

  10. 10
    Giun-Yi Hung, Jiun-Lin Horng, Hsiu-Ju Yen, Chueh-Chuan Yen, Wei-Ming Chen, Paul Chih-Hsueh Chen, Hung-Ta Hondar Wu, Hong-Jen Chiou, Incidence Patterns of Primary Bone Cancer in Taiwan (2003–2010): A Population-Based Study, Annals of Surgical Oncology, 2014, 21, 8, 2490

    CrossRef

  11. 11
    Huiwen Liu, Lu Huang, Zhongzu Zhang, Zhanming Zhang, Zhiming Yu, Xiang Chen, Zhuo Chen, Yongping Zen, Dong Yang, Zhimin Han, Yong Shu, Min Dai, Kai Cao, LIM Mineralization Protein-1 Inhibits the Malignant Phenotypes of Human Osteosarcoma Cells, International Journal of Molecular Sciences, 2014, 15, 4, 7037

    CrossRef

  12. 12
    Fei Zhang, Wei Huang, Meixia Sheng, Tielong Liu, MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients, Tumor Biology, 2014,

    CrossRef

  13. 13
    Max Brosa, Xavier García del Muro, Jaume Mora, Alba Villacampa, Tamara Pozo-Rubio, Laia Cubells, Carmen Montoto, Orphan drugs revisited: cost–effectiveness analysis of the addition of mifamurtide to the conventional treatment of osteosarcoma, Expert Review of Pharmacoeconomics & Outcomes Research, 2014, 1

    CrossRef

  14. 14
    Caroline Hadley, Loyola V. Gressot, Akash J. Patel, Lisa L. Wang, Ricardo J. Flores, William E. Whitehead, Thomas G. Luerssen, Andrew Jea, Robert J. Bollo, Osteosarcoma of the cranial vault and skull base in pediatric patients, Journal of Neurosurgery: Pediatrics, 2014, 13, 4, 380

    CrossRef

  15. 15
    Ninna Aggerholm-Pedersen, Katja Maretty-Nielsen, Johnny Keller, Steen Baerentzen, Henrik Schrøder, Peter Holmberg Jørgensen, Bjarne Hauge Hansen, Ole Steen Nielsen, Akmal Safwat, The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database, Acta Oncologica, 2014, 1

    CrossRef

  16. 16
    Kjetil Berner, Tom Børge Johannesen, Aasmund Berner, Hans Kristian Haugland, Bodil Bjerkehagen, Per J. Bøhler, Øyvind S. Bruland, Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma, Acta Oncologica, 2014, 1

    CrossRef

  17. 17
    Caroline M. Piskun, Timothy J. Stein, β-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour, Veterinary and Comparative Oncology, 2014, 12, 4
  18. 18
    Worawut Choeyprasert, Rungrote Natesirinilkul, Pimlak Charoenkwan, Somjai Sittipreechacharn, Carboplatin and Doxorubicin in Treatment of Pediatric Osteosarcoma: A 9-year Single Institute Experience in the Northern Region of Thailand, Asian Pacific Journal of Cancer Prevention, 2013, 14, 2, 1101

    CrossRef

  19. 19
    Richard Gorlick, Katherine Janeway, Stephen Lessnick, R. Lor Randall, Neyssa Marina, Children's Oncology Group's 2013 blueprint for research: Bone tumors, Pediatric Blood & Cancer, 2013, 60, 6
  20. 20
    C.A. Stiller, A. Trama, D. Serraino, S. Rossi, C. Navarro, M.D. Chirlaque, P.G. Casali, Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project, European Journal of Cancer, 2013, 49, 3, 684

    CrossRef

  21. 21
    Vincenza Rita Lo Vasco, Martina Leopizzi, Caterina Chiappetta, Chiara Puggioni, Claudio Di Cristofano, Carlo Della Rocca, Expression of Phosphoinositide-specific phospholipase C enzymes in human osteosarcoma cell lines, Journal of Cell Communication and Signaling, 2013, 7, 2, 141

    CrossRef

  22. 22
    Jeremy Lewin, Ajay Puri, Richard Quek, Roger Ngan, Ana Patricia Alcasabas, David Wood, David Thomas, Management of sarcoma in the Asia-Pacific region: resource-stratified guidelines, The Lancet Oncology, 2013, 14, 12, e562

    CrossRef

  23. 23
    Lifeng Liu, Ying Xu, Russel J. Reiter, Melatonin inhibits the proliferation of human osteosarcoma cell line MG-63, Bone, 2013, 55, 2, 432

    CrossRef

  24. 24
    Haixia Zhang, Haotong Wu, Junheng Zheng, Pei Yu, Lixiao Xu, Pan Jiang, Jin Gao, Hua Wang, Yan Zhang, Transforming Growth Factor β1 Signal is Crucial for Dedifferentiation of Cancer Cells to Cancer Stem Cells in Osteosarcoma, STEM CELLS, 2013, 31, 3
  25. 25
    Yucai Wang, Jun Chen, Dianzhong Zhang, Yunfei Zhang, Yanhua Wen, Lihong Li, Lianhe Zheng, Tumoricidal effects of a selenium (Se)-polysaccharide from Ziyang green tea on human osteosarcoma U-2 OS cells, Carbohydrate Polymers, 2013, 98, 1, 1186

    CrossRef

  26. 26
    George T. Calvert, R. Lor Randall, Kevin B. Jones, Lisa Cannon-Albright, Stephen Lessnick, Joshua D. Schiffman, At-Risk Populations for Osteosarcoma: The Syndromes and Beyond, Sarcoma, 2012, 2012, 1

    CrossRef

  27. 27
    Sarah K. Gray, Meghan E. McGee-Lawrence, Jennifer L. Sanders, Keith W. Condon, Chung-Jui Tsai, Seth W. Donahue, Black bear parathyroid hormone has greater anabolic effects on trabecular bone in dystrophin-deficient mice than in wild type mice, Bone, 2012, 51, 3, 578

    CrossRef

  28. 28
    Santosh S. Dhule, Patrice Penfornis, Trivia Frazier, Ryan Walker, Joshua Feldman, Grace Tan, Jibao He, Alina Alb, Vijay John, Radhika Pochampally, Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma, Nanomedicine: Nanotechnology, Biology and Medicine, 2012, 8, 4, 440

    CrossRef

  29. 29
    J E Davies, S Neidle, D G Taylor, Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?, British Journal of Cancer, 2012, 106, 1, 14

    CrossRef

  30. 30
    Pingxian Tan, Changye Zou, Bicheng Yong, Ju Han, Longjuan Zhang, Qiao Su, Junqiang Yin, Jin Wang, Gang Huang, Tingsheng Peng, Jingnian Shen, Expression and prognostic relevance of PRAME in primary osteosarcoma, Biochemical and Biophysical Research Communications, 2012, 419, 4, 801

    CrossRef

  31. 31
    Li-Min Yang, Xiu-Hua Li, Cui-Fen Bao, Glutathione S-transferase P1 and DNA Polymorphisms with the Response to Chemotherapy and the Prognosis of Bone Tumor, Asian Pacific Journal of Cancer Prevention, 2012, 13, 11, 5883

    CrossRef

  32. 32
    Jeremy Whelan, Anne McTiernan, Nicola Cooper, Yuen K Wong, Matthew Francis, Sally Vernon, Sandra J. Strauss, Incidence and survival of malignant bone sarcomas in England 1979–2007, International Journal of Cancer, 2012, 131, 4
  33. 33
    Pattara Wiromrat, Arunee Jetsrisuparb, Patcharee Komvilaisak, Winai Sirichativapee, Supot Kamsa-Ard, Surapon Wiangnon, Incidence and Survival Rates among Pediatric Osteogenic Sarcoma Cases in Khon Kaen, Thailand, 1985-2010, Asian Pacific Journal of Cancer Prevention, 2012, 13, 9, 4281

    CrossRef

  34. 34
    Pui Yan Jenny Chung, Wim Van Hul, Paget's Disease of Bone: Evidence for Complex Pathogenetic Interactions, Seminars in Arthritis and Rheumatism, 2012, 41, 5, 619

    CrossRef

  35. 35
    Cristiana Capriani, Dinaz Irani, John P Bilezikian, Safety of osteoanabolic therapy: A decade of experience, Journal of Bone and Mineral Research, 2012, 27, 12
  36. 36
    Lisa Mirabello, Kai Yu, Sonja I Berndt, Laurie Burdett, Zhaoming Wang, Salma Chowdhury, Kedest Teshome, Arinze Uzoka, Amy Hutchinson, Tom Grotmol, Chester Douglass, Richard B Hayes, Robert N Hoover, Sharon A Savage, A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma, BMC Cancer, 2011, 11, 1, 209

    CrossRef

  37. 37
    Andrea Y. Angstadt, Alison Motsinger-Reif, Rachael Thomas, William C. Kisseberth, C. Guillermo Couto, Dawn L. Duval, Dahlia M. Nielsen, Jaime F. Modiano, Matthew Breen, Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: Signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart, Genes, Chromosomes and Cancer, 2011, 50, 11
  38. 38
    Jakob K. Anninga, Hans Gelderblom, Marta Fiocco, Judith R. Kroep, Antoni H.M. Taminiau, Pancras C.W. Hogendoorn, R. Maarten Egeler, Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?, European Journal of Cancer, 2011, 47, 16, 2431

    CrossRef

  39. 39
    Harry Comber, Sandra Deady, Erin Montgomery, Anna Gavin, Drinking water fluoridation and osteosarcoma incidence on the island of Ireland, Cancer Causes & Control, 2011, 22, 6, 919

    CrossRef

  40. 40
    Lisa Mirabello, Ruth Pfeiffer, Gwen Murphy, Najat C. Daw, Ana Patiño-Garcia, Rebecca J. Troisi, Robert N. Hoover, Chester Douglass, Joachim Schüz, Alan W. Craft, Sharon A. Savage, Height at diagnosis and birth-weight as risk factors for osteosarcoma, Cancer Causes & Control, 2011, 22, 6, 899

    CrossRef

  41. 41
    Sharon A. Savage, Lisa Mirabello, Using Epidemiology and Genomics to Understand Osteosarcoma Etiology, Sarcoma, 2011, 2011, 1

    CrossRef

  42. 42
    Katherine A. Janeway, Carl R. Walkley, Modeling human osteosarcoma in the mouse: From bedside to bench, Bone, 2010, 47, 5, 859

    CrossRef

  43. 43
    Richard Gorlick, Chand Khanna, Osteosarcoma, Journal of Bone and Mineral Research, 2010, 25, 4
  44. 44
    Jennifer Worch, Katherine K. Matthay, John Neuhaus, Robert Goldsby, Steven G. DuBois, Osteosarcoma in children 5 years of age or younger at initial diagnosis, Pediatric Blood & Cancer, 2010, 55, 2
  45. 45
    Sameer Bakhshi, Venkatraman Radhakrishnan, Prognostic markers in osteosarcoma, Expert Review of Anticancer Therapy, 2010, 10, 2, 271

    CrossRef

  46. 46
    Colin Moore, Don Eslin, Alejandro Levy, Jessica Roberson, Vincent Giusti, Robert Sutphin, Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma, Pediatric Blood & Cancer, 2010, 55, 6
  47. 47
    Robert Grimer, Nick Athanasou, Craig Gerrand, Ian Judson, Ian Lewis, Bruce Morland, David Peake, Beatrice Seddon, Jeremy Whelan, UK Guidelines for the Management of Bone Sarcomas, Sarcoma, 2010, 2010, 1

    CrossRef

  48. 48
    Lisa Mirabello, Osteosarcoma: Genetics of Inherited Susceptibility, eLS,